MAISON POMMERY & ASSOCIES (POMRY) - Total Liabilities
Based on the latest financial reports, MAISON POMMERY & ASSOCIES (POMRY) has total liabilities worth €932.51 Million EUR (≈ $1.09 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See how liquid is MAISON POMMERY & ASSOCIES's working capital to evaluate short-term liquidity relative to the company's equity base.
MAISON POMMERY & ASSOCIES - Total Liabilities Trend (2021–2024)
This chart illustrates how MAISON POMMERY & ASSOCIES's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see MAISON POMMERY & ASSOCIES asset portfolio.
MAISON POMMERY & ASSOCIES Competitors by Total Liabilities
The table below lists competitors of MAISON POMMERY & ASSOCIES ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kyongbo Pharmaceutical Co Ltd
KO:214390
|
Korea | ₩220.58 Billion |
|
Suraj Estate Developers Ltd.
NSE:SURAJEST
|
India | Rs9.68 Billion |
|
Rimbunan Sawit Bhd
KLSE:5113
|
Malaysia | RM390.61 Million |
|
South Basic Chemicals JSC
VN:CSV
|
Vietnam | ₫519.44 Billion |
|
NIP Group Inc. American Depositary Shares
NASDAQ:NIPG
|
USA | $73.10 Million |
|
Kingcan Holdings Ltd
TW:8411
|
Taiwan | NT$7.27 Billion |
|
Veracruz Properties SOCIMI SA
MC:YVCP
|
Spain | €41.37 Million |
|
Terns Pharmaceuticals Inc
NASDAQ:TERN
|
USA | $17.59 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down MAISON POMMERY & ASSOCIES's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See MAISON POMMERY & ASSOCIES balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.70 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MAISON POMMERY & ASSOCIES's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MAISON POMMERY & ASSOCIES (2021–2024)
The table below shows the annual total liabilities of MAISON POMMERY & ASSOCIES from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €939.37 Million ≈ $1.10 Billion |
+1.83% |
| 2023-12-31 | €922.47 Million ≈ $1.08 Billion |
+2.85% |
| 2022-12-31 | €896.94 Million ≈ $1.05 Billion |
+4.22% |
| 2021-12-31 | €860.62 Million ≈ $1.01 Billion |
-- |
About MAISON POMMERY & ASSOCIES
Maison Pommery & Associés, together with its subsidiaries, produces and sells wines and champagnes in France, Europe, and internationally. It operates through Champagne and Other Items, and Sable and Provence Wines segments. The company was formerly known as Vranken-Pommery Monopole Société Anonyme and changed its name to Maison Pommery & Associés in January 2026. Maison Pommery & Associés was fo… Read more